VCU Develops Cancer Literacy Assessment Tool
Researchers at Virginia Commonwealth University’s Massey Cancer Center have developed what VCU officials say is the first and only tool that can accurately measure cancer health literacy.
Researchers at Virginia Commonwealth University's Massey Cancer Center have developed what VCU officials say is the first and only tool that can accurately measure cancer health literacy.
"This tool has the potential to improve communication and understanding between physicians and patients, which, in turn, could lead to better clinical outcomes," university officials said.
Recently published in the Journal of Health Communications, the Cancer Health Literacy Study was conducted over four years and involved 1,306 African-American and Caucasian patients from Massey and surrounding oncology clinics. The researchers developed an evaluation tool called the Cancer Health Literacy Test (CHLT)-30 to measure cancer health literacy along a continuum. The test, which was administered to the patients via a touch-screen device, asked 30 questions about cancer treatment, medication side effects and more.
Six of the 30 questions (CHLT-6) were specifically designed to quickly identify individuals with limited CHL. Together, the tests were found to accurately measure CHL and quickly identify patients with limited CHL. This study reported that 18 percent of cancer patients have limited CHL, with an overrepresentation of African-American, undereducated and low-income patients.
Using this tool, it takes just one to two minutes in the doctors office waiting room to identify patients with limited CHL. Then this information can be digitally communicated to the doctors prior to seeing the patients, so that they are prepared to talk with the patients in terms they can understand, said Levent Dumenci, the studys lead researcher. This simple change could lead to big improvements in health outcomes.
In further studies, the researchers hope to evaluate the CHL of Hispanic patients because prior research has indicated disparities in that populations health literacy. To do so, the CHL test will need to be translated into Spanish in order to remove the language barrier.
The study is available here.
"This tool has the potential to improve communication and understanding between physicians and patients, which, in turn, could lead to better clinical outcomes," university officials said.
Recently published in the Journal of Health Communications, the Cancer Health Literacy Study was conducted over four years and involved 1,306 African-American and Caucasian patients from Massey and surrounding oncology clinics. The researchers developed an evaluation tool called the Cancer Health Literacy Test (CHLT)-30 to measure cancer health literacy along a continuum. The test, which was administered to the patients via a touch-screen device, asked 30 questions about cancer treatment, medication side effects and more.
Six of the 30 questions (CHLT-6) were specifically designed to quickly identify individuals with limited CHL. Together, the tests were found to accurately measure CHL and quickly identify patients with limited CHL. This study reported that 18 percent of cancer patients have limited CHL, with an overrepresentation of African-American, undereducated and low-income patients.
Using this tool, it takes just one to two minutes in the doctors office waiting room to identify patients with limited CHL. Then this information can be digitally communicated to the doctors prior to seeing the patients, so that they are prepared to talk with the patients in terms they can understand, said Levent Dumenci, the studys lead researcher. This simple change could lead to big improvements in health outcomes.
In further studies, the researchers hope to evaluate the CHL of Hispanic patients because prior research has indicated disparities in that populations health literacy. To do so, the CHL test will need to be translated into Spanish in order to remove the language barrier.
The study is available here.
More for you
Loading data for hdm_tax_topic #better-outcomes...